Rita Nanda Selected Research

Leukopenia

5/2021	Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study.
9/2014	Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rita Nanda Research Topics

Disease

71	Breast Neoplasms (Breast Cancer) 05/2024 - 02/2006
54	Neoplasms (Cancer) 12/2023 - 12/2005
28	Triple Negative Breast Neoplasms 05/2024 - 12/2008
15	Pathologic Complete Response 05/2023 - 05/2013
5	Disease Progression 01/2023 - 01/2018
4	Residual Neoplasm 10/2022 - 07/2016
3	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2013
2	Leukopenia 05/2021 - 09/2014
2	Fatigue 05/2021 - 01/2020
2	Diarrhea 05/2021 - 06/2020
2	Neutropenia 05/2021 - 01/2016
2	Brain Neoplasms (Brain Tumor) 10/2018 - 08/2014
2	Carcinoma (Carcinomatosis) 10/2017 - 02/2006
1	Microsatellite Instability 08/2022
1	Cardiotoxicity 02/2022
1	Left Ventricular Dysfunction 02/2022
1	Hyperglycemia 10/2021
1	Enteritis 10/2021
1	Posterior Leukoencephalopathy Syndrome 10/2021
1	Dizziness (Lightheadedness) 10/2021
1	Lactic Acidosis 10/2021
1	Mental Fatigue 10/2021
1	Premature Menopause 08/2021
1	Amenorrhea 08/2021
1	Infertility (Sterility) 08/2021

Drug/Important Bio-Agent (IBA)

19	Hormones (Hormone)IBA 12/2023 - 04/2011
15	Trastuzumab (Herceptin)FDA Link 12/2023 - 05/2007
12	Estrogen ReceptorsIBA 12/2023 - 12/2005
10	Immune Checkpoint InhibitorsIBA 03/2024 - 10/2017
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2016
8	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 09/2014
7	Capecitabine (Xeloda)FDA Link 05/2024 - 06/2016
7	Progesterone Receptors (Progesterone Receptor)IBA 12/2023 - 12/2005
7	human ERBB2 proteinIBA 12/2020 - 05/2007
6	Lapatinib (GW572016)FDA Link 01/2023 - 05/2013
5	NivolumabIBA 05/2024 - 10/2017
5	pembrolizumabIBA 01/2023 - 01/2016
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 05/2013
4	Ado-Trastuzumab EmtansineIBA 02/2022 - 01/2021
3	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 01/2018
3	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 05/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2006
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 08/2017
3	atezolizumabIBA 01/2020 - 10/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2008
3	Letrozole (Femara)FDA LinkGeneric 01/2020 - 05/2013
3	Estrogens (Estrogen)FDA Link 01/2020 - 09/2008
3	LigandsIBA 01/2019 - 09/2008
2	Messenger RNA (mRNA)IBA 12/2023 - 01/2023
2	Circulating Tumor DNAIBA 12/2023 - 01/2020
2	Phenobarbital (Luminal)FDA Link 01/2023 - 02/2006
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
2	olaparibIBA 12/2021 - 12/2020
2	durvalumabIBA 12/2021 - 10/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 10/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 10/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2014
2	enzalutamideIBA 01/2020 - 01/2018
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 07/2013
2	TOR Serine-Threonine KinasesIBA 01/2020 - 05/2013
2	veliparibIBA 08/2017 - 07/2016
2	Carboplatin (JM8)FDA LinkGeneric 08/2017 - 07/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2016 - 01/2016
2	Mifepristone (RU 486)FDA Link 01/2016 - 09/2014
2	Albumin-Bound Paclitaxel FDA Link 01/2016 - 06/2015
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2016 - 09/2014
1	trebananibIBA 12/2023
1	InterferonsIBA 12/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	AndrogensIBA 01/2023
1	Hematoxylin (Haematoxylon)IBA 01/2023
1	ApolipoproteinsIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	STA 9090IBA 12/2022
1	Conjugate VaccinesIBA 10/2022
1	GlycosphingolipidsIBA 10/2022
1	Globo-HIBA 10/2022
1	Immunoglobulin G (IgG)IBA 10/2022
1	Immunoglobulin M (IgM)IBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	pertuzumabIBA 11/2021
1	urelumabIBA 10/2021
1	cabiralizumabIBA 10/2021
1	ganitumabIBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ASP4132IBA 10/2021

Therapy/Procedure

32	Therapeutics 12/2023 - 04/2011
25	Neoadjuvant Therapy 12/2023 - 05/2013
24	Drug Therapy (Chemotherapy) 03/2024 - 05/2007
9	Immunotherapy 03/2024 - 01/2016
3	Meditation 05/2024 - 01/2023
3	Massage (Zone Therapy) 05/2024 - 01/2023
3	Music Therapy 05/2024 - 01/2023
2	Investigational Therapies (Experimental Therapy) 12/2023 - 11/2021
1	Injections 08/2022